Matt Gamber’s Biotech Newsletter
Matt GamberWeekly posts on small and mid-cap biotech stocks. 100% independent and reader supported with no company sponsored content or hedge fund compensation of any kind. See free performance posts for more information. Not financial advice, for research purposes.
| Platform |  | Pricing | Freemium |
|---|---|---|---|
| Publishes | Weekly | Issues | 41 |
| Subscribers | Read | mattbiotech.substack.com |
Curious about how many subscribers Matt Gamber’s Biotech Newsletter has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #141 |
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Q4 2024 Earnings Call Recaps, Part 1
This is Part 1 of paid subscriber exclusive long-form content. ARQT, GERN, CRDF, APLS.
Free Post: February Performance Update
Hi everyone! This is a 100% free post for all subscribers. If you enjoy my writing and have been reading the intro to the paywalled articles every week, may I suggest subscribing so you can receive 1 to 2 full articles weekly in your inbox?...
Yes, Biotech Is Ailing. Here Are My Top Five Defensive Picks.
Did you know Warren Buffett's first rule of investing is Never Lose Money? I bet you have NEVER heard that before. :-)
Quick Thoughts On Potential SpringWorks Acquistion And Position Sizing
Post info: 1,185 words, reading time of 6 minutes.
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
Frequently Asked Questions
How can I access the email archive for Matt Gamber’s Biotech Newsletter?
You can find recent issues that have been published by Matt Gamber’s Biotech Newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Matt Gamber’s Biotech Newsletter have?
To see how many people subscribe to Matt Gamber’s Biotech Newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Matt Gamber’s Biotech Newsletter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Matt Gamber’s Biotech Newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Matt Gamber’s Biotech Newsletter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Matt Gamber’s Biotech Newsletter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Matt Gamber’s Biotech Newsletter?
Scroll up to where it says Similar Newsletters to see other publications like Matt Gamber’s Biotech Newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Matt Gamber’s Biotech Newsletter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.